Australian Leisure Stock News

Lynas Rare Earths reported full year 2026 results, with sales of A$977.95 million and net income of A$222.35 million from continuing operations. The wide gap between sales and earnings, reflected in basic EPS of A$0.2215, highlights how operating leverage currently shapes Lynas Rare Earths' profitability profile. With this sharp step up in full year earnings on the table, we will look at how it reframes the investment narrative for Lynas Rare Earths. Scan how Lynas Rare Earths’ earnings...

What Yancoal’s new coal sales framework means for investors Yancoal Australia (ASX:YAL) has renewed framework agreements to sell coal to Yankuang Energy Group and YIT for November and December 2026, setting upper limits on transaction values and clarifying how these dealings will be conducted. The arrangements outline ordinary course trading, arm’s length pricing and compliance with Hong Kong listing rules. This gives you clearer visibility on how related party and affiliate coal volumes...

Mineral Resources reported full year 2026 sales of A$6,461 million and net income of A$1,061 million, declared an annual dividend of A$0.83 per share, and confirmed that ASIC has closed its investigation without taking enforcement action. The move from a prior year net loss to positive earnings, alongside removal of regulatory uncertainty, may influence how Mineral Resources' underlying business quality and risk profile are viewed. With ASIC closing its investigation and profitability...

PYC Therapeutics reported full year results for the 12 months to 30 June 2026, with revenue of A$39.68 million, a net loss of A$43.34 million, and basic and diluted loss per share of A$0.0591. The biotech reduced its annual loss compared with the prior year while lifting revenue, indicating progress on scaling its platform despite ongoing costs. The next step is to examine how PYC Therapeutics' higher full year revenue and narrower loss influence the broader investment narrative. Scan the...

Oil prices are holding near US$100 as renewed conflict in the Middle East keeps supply risks front and centre, and that puts steady, well funded Australian companies in a different league. Higher input costs can squeeze fragile balance sheets. Strong cash reserves and sensible debt levels give resilient businesses more room to defend profits. This article walks through three stocks from our solid fundamentals pool that fit that description. The stocks covered next are a small sample of what a...

Lovisa Holdings dividend and earnings announcement Lovisa Holdings (ASX:LOV) has combined its latest full year earnings release with a higher ordinary final dividend, distributing 100% of full year earnings and lifting total dividends by 11.7%. The A$23.60 share price has recovered over the past three months with a 90 day share price return of 12.81%. However, the share price is still down 19.43% year to date and total shareholder return over one year has declined 41.81%, signalling fading...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

WiseTech Global recently reported full-year 2026 results, with sales rising to US$1,395.9 million, net income of US$178.7 million, a 14% higher fully franked final dividend of US$0.088 per share, and new fiscal 2027 revenue guidance of US$1.48 billion to US$1.54 billion, while also appointing Jeff Howard as incoming CFO and adding Tim Ebbeck to its board. These updates collectively reshape how investors might view WiseTech’s growth profile, capital allocation, and governance depth as it...

Why the Centenario deal is back in focus for Liontown stock The fresh farm in agreement for the Centenario lithium brine project in Argentina gives Liontown (ASX:LTR) a new growth option in South America alongside its established Australian hard rock operations. This section looks at what the Centenario structure means for Liontown’s capital commitments, potential ownership path and partnership with NEXT Lithium Corp, and how those elements might matter for investors tracking the stock. Over...

Dalrymple Bay Infrastructure recently reported past half-year results to 30 June 2026, with revenue of A$434.17 million and net income of A$49.21 million, and confirmed a quarterly cash dividend of A$0.0675 per stapled security payable on 17 September 2026. The combination of higher revenue and earnings compared with a year earlier, alongside a maintained cash distribution, highlights the asset’s income-focused profile and the importance of its contracted, regulated infrastructure...

Perseus Mining (ASX:PRU) has drawn fresh attention after reporting full year 2026 results alongside an updated capital return package. The company announced higher sales and net income, a larger on market buyback and a higher ordinary dividend. Over the past year Perseus Mining’s share price has gained momentum, with a 30 day share price return of 24.45% and a 90 day return of 35.13%. The 1 year total shareholder return of 62.58% and very large 5 year total shareholder return suggest recent...

Tasmea Limited has already reported its full-year 2026 results, with sales of A$1,293.31 million and net income of A$71.27 million, and declared a fully franked final dividend of A$0.085 per share payable on October 30, 2026. The combination of higher earnings and a larger fully franked dividend highlights Tasmea’s ability to convert revenue growth into distributable profits for shareholders. We’ll now examine how Tasmea’s higher fully franked dividend and stronger earnings performance...

Flight Centre Travel Group (ASX:FLT) recently reported its full year 2026 results, alongside a dividend announcement that drew fresh attention to the stock and its latest move in sales, profits and shareholder returns. Those results and the higher dividend landed alongside other company news, including the appointment of experienced board member Gareth Turner and the planned retirement of long‑serving director Rob Baker at the 2026 AGM. Together, these developments keep Flight Centre Travel...

Domino's Pizza Enterprises recently reported full-year results showing sales of A$2.05 billion versus A$2.30 billion a year earlier, alongside a net loss of A$134.16 million and basic loss per share of A$1.418. Despite this wider loss and lower sales, the company declared an increased ordinary dividend of A$0.325 per share for the six months to June 28 2026, with an ex-dividend date of September 1 2026. We’ll now examine how the wider full-year loss, alongside an increased dividend, may...

As the Australian market prepares for a positive opening, buoyed by strong performances on Wall Street and easing interest rate concerns, investors are keenly observing opportunities that may arise from these favorable conditions. In such an environment, identifying stocks that are estimated to be trading below their fair value can be particularly appealing, as they offer potential for growth amidst broader market optimism.

The Australian market is set to open positively today, buoyed by strong overnight performances on Wall Street and easing fears of interest rate hikes. In this context, investors might be exploring various opportunities, including penny stocks—an investment area that continues to attract attention despite its somewhat outdated name. These smaller or newer companies can offer significant growth potential when they possess solid financials and a clear path forward.

Zimplats Holdings Limited recently reported full-year results for the period ended June 30, 2026, with sales rising to US$1,298.83 million from US$826.59 million and net income increasing to US$276.67 million from US$40.5 million a year earlier. The sharp improvement in basic earnings per share from US$0.38 to US$2.57 highlights a step-change in profitability over the past year. With this strong expansion in sales and earnings, we will now examine how the improved profitability shapes...

Endeavour Group (ASX:EDV) has entered the spotlight after reporting full year net income of A$52 million, which was sharply lower than the previous year, and confirming a reduced fully franked dividend of A$0.012 per share. Over the past quarter Endeavour Group’s share price return of 9.76% contrasts with a share price decline of 9.94% over the past month and a 1 year total shareholder return that is down 9.53%. This suggests recent momentum has softened as investors absorb the weaker...

Magellan Financial Group (ASX:MFG) has attracted fresh attention after releasing full year 2026 results that showed lower revenue and net income, along with a new A$0.255 dividend and confirmation of upcoming key dividend dates. Since the start of the year, Magellan Financial Group’s share price return has fallen 11.81%, with a 30 day share price return down 16.20% ahead of the A$0.255 dividend and address change updates. However, the 3 year total shareholder return of 18.84% contrasts with a...

Ramsay Health Care earnings jump and dividend update Ramsay Health Care (ASX:RHC) has drawn fresh investor attention after reporting higher full year sales, revenue and net income for the year to June 30, 2026, alongside an increased fully franked dividend. Over the past year, Ramsay Health Care's share price has gained momentum, with a 30 day share price return of 17.98% and a 90 day return of 42.79%. The 1 year total shareholder return of 58.31% sits against a more modest 3 year total...

Data#3 Limited has already reported full-year 2026 results, with revenue of A$907.30 million, net income of A$54.52 million, and higher earnings per share than the prior year. The company also lifted its fully franked final dividend to A$0.1825 per share, resulting in a 13.0% full-year dividend increase and a payout ratio of 90.3%. We’ll now examine how the stronger earnings and higher dividend payout shape Data#3’s existing investment narrative and risk-return balance. The future of work is...

Wesfarmers Limited recently reported its full-year results for the year ended June 30, 2026, with sales of A$47.27 billion, net income of A$2.87 billion and basic earnings per share from continuing operations of A$2.534, alongside announcing a fully franked ordinary dividend of A$1.20 per share for the half-year. Despite a slight year-on-year decline in net income and earnings per share, the decision to lift the fully franked dividend signals management’s confidence in Wesfarmers’ cash...

Harvey Norman Holdings Limited recently reported full-year results to June 30, 2026, with net income of A$528.46 million and diluted earnings per share from continuing operations of A$0.4236, and also declared a fully franked ordinary dividend of A$0.13 per share for the half year, payable on November 12, 2026. Despite only a modest lift in net income and earnings per share compared with the prior year, the company’s decision to pair this with a fully franked dividend highlights the...

Telix Pharmaceuticals (ASX:TLX) is in focus after completing enrollment in its Phase 3 BiPASS study for prostate cancer imaging and as investors watch for an upcoming FDA decision on its Pixclara brain cancer imaging agent. The recent BiPASS milestone and the upcoming Pixclara FDA decision are contributing to solid momentum for Telix Pharmaceuticals, with the share price at A$16.47 and a 90 day share price return of 23.74% contributing to a 5 year total shareholder return of 159.78%. Scan for...